Cartesian Therapeutics
RNAC
RNAC
48 hedge funds and large institutions have $235M invested in Cartesian Therapeutics in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
1.2%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
9
Increased
27
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
$22.2M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$18.6M |
| 3 |
PA
Perceptive Advisors
New York
|
$15.8M |
| 4 |
BlackRock
New York
|
$9.94M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$4.32M |
